Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharyn D Baker

Showing results (111-120 of 166) with videos related to

Pageof 17
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2013
Cellular uptake of imatinib into leukemic cells is independent of human organic cation transporter 1 (OCT1)Anne T Nies, Elke Schaeffeler, Heiko van der Kuip, et al.
Leukemia & Lymphoma|June 2, 2016
Transcriptome profiling of patient derived xenograft models established from pediatric acute myeloid leukemia patients confirm maintenance of FLT3-ITD mutationChristina D Drenberg, Daelynn R Buelow, Stanley B Pounds, et al.
Cancer|May 12, 2017
Palmar-plantar erythrodysesthesia syndrome following treatment with high-dose methotrexate or high-dose cytarabineSeth E Karol, Wenjian Yang, Colton Smith, et al.
Medrxiv : the Preprint Server for Health Sciences|March 4, 2025
Genomewide Screen Identifies Peroxisomal Role in APOL1 PodocytopathyJiyoung Kim, Isaac Z Karel, Huijuan Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Phase I study of docosahexaenoic acid-paclitaxel: a taxane-fatty acid conjugate with a unique pharmacology and toxicity profileAntonio C Wolff, Ross C Donehower, M Katherine Carducci, et al.
Cancer Research|December 19, 2015
Multikinase Inhibitors Induce Cutaneous Toxicity through OAT6-Mediated Uptake and MAP3K7-Driven Cell DeathEric I Zimmerman, Alice A Gibson, Shuiying Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2012
Influence of smoking on the pharmacokinetics and toxicity profiles of taxane therapyAnne-Joy M de Graan, Walter J Loos, Lena E Friberg, et al.
Cancers|January 8, 2023
TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with <i>TP53</i> Mutation/DeletionEric D Eisenmann, Jack C Stromatt, Sydney Fobare, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2013
Emergence of polyclonal FLT3 tyrosine kinase domain mutations during sequential therapy with sorafenib and sunitinib in FLT3-ITD-positive acute myeloid leukemiaSharyn D Baker, Eric I Zimmerman, Yong-Dong Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2008
Pharmacodynamic-guided modified continuous reassessment method-based, dose-finding study of rapamycin in adult patients with solid tumorsAntonio Jimeno, Michelle A Rudek, Peter Kulesza, et al.
Pageof 17

Showing results (111-120 of 166) with videos related to

Sort By:
Pageof 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2013
Cellular uptake of imatinib into leukemic cells is independent of human organic cation transporter 1 (OCT1)Anne T Nies, Elke Schaeffeler, Heiko van der Kuip, et al.
Leukemia & Lymphoma|June 2, 2016
Transcriptome profiling of patient derived xenograft models established from pediatric acute myeloid leukemia patients confirm maintenance of FLT3-ITD mutationChristina D Drenberg, Daelynn R Buelow, Stanley B Pounds, et al.
Cancer|May 12, 2017
Palmar-plantar erythrodysesthesia syndrome following treatment with high-dose methotrexate or high-dose cytarabineSeth E Karol, Wenjian Yang, Colton Smith, et al.
Medrxiv : the Preprint Server for Health Sciences|March 4, 2025
Genomewide Screen Identifies Peroxisomal Role in APOL1 PodocytopathyJiyoung Kim, Isaac Z Karel, Huijuan Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Phase I study of docosahexaenoic acid-paclitaxel: a taxane-fatty acid conjugate with a unique pharmacology and toxicity profileAntonio C Wolff, Ross C Donehower, M Katherine Carducci, et al.
Cancer Research|December 19, 2015
Multikinase Inhibitors Induce Cutaneous Toxicity through OAT6-Mediated Uptake and MAP3K7-Driven Cell DeathEric I Zimmerman, Alice A Gibson, Shuiying Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2012
Influence of smoking on the pharmacokinetics and toxicity profiles of taxane therapyAnne-Joy M de Graan, Walter J Loos, Lena E Friberg, et al.
Cancers|January 8, 2023
TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with <i>TP53</i> Mutation/DeletionEric D Eisenmann, Jack C Stromatt, Sydney Fobare, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2013
Emergence of polyclonal FLT3 tyrosine kinase domain mutations during sequential therapy with sorafenib and sunitinib in FLT3-ITD-positive acute myeloid leukemiaSharyn D Baker, Eric I Zimmerman, Yong-Dong Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2008
Pharmacodynamic-guided modified continuous reassessment method-based, dose-finding study of rapamycin in adult patients with solid tumorsAntonio Jimeno, Michelle A Rudek, Peter Kulesza, et al.
Pageof 17